ALLISON MANNING: Open Payments
NPI 1477818896 · JACKSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 39 payments from 11 companies in 2025. Trend: 2023 $554 · 2024 $384 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $159 |
| Novo Nordisk Inc | 13 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Amgen Inc. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Phathom Pharmaceuticals, Inc. | 2 | $20 |
| PFIZER INC. | 1 | $19 |
| KYOWA KIRIN, INC. | 1 | $19 |
Products named: Ozempic, QULIPTA, CAPLYTA, TRELEGY ELLIPTA, OTEZLA, Kerendia, VRAYLAR, TEZSPIRE.
Industry payments across KY — which companies pay providers there.
